EXACT SCIENCES CORP
EXAS
22 insider filings · Latest: Mar 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Nov 19 8:11 PM | ORVILLE JACOB A | Proposed Sale | 5,000 | $75.00 | $375.0K | — | View → |
| Nov 19, 2025 | Nov 19 5:04 PM | Herriott James | Proposed Sale | 1,000 | $70.00 | $70.0K | — | View → |
| Nov 4, 2025 | Nov 4 3:25 PM | Baranick Brian | Proposed Sale | 2,858 | $70.08 | $200.3K | — | View → |
| Nov 4, 2025 | Nov 4 3:22 PM | Herriott James | Proposed Sale | 1,500 | $70.08 | $105.1K | — | View → |
| Oct 24, 2025 | Oct 24 3:08 PM | Zanotti Katherine S | Proposed Sale | 12,000 | $65.00 | $780.0K | — | View → |
| Oct 9, 2025 | Oct 9 3:23 PM | Herriott James | Proposed Sale | 1,500 | $60.00 | $90.0K | — | View → |
| Oct 9, 2025 | Oct 9 3:18 PM | Doyle James Edward | Proposed Sale | 2,000 | $60.00 | $120.0K | — | View → |
| Aug 13, 2025 | Aug 13 2:09 PM | Doyle James Edward | Proposed Sale | 1,485 | $42.02 | $62.4K | — | View → |
| Jul 16, 2025 | Jul 16 8:22 PM | Sebelius Kathleen | Proposed Sale | 8,164 | $53.11 | $433.6K | — | View → |
| Jun 13, 2025 | Jun 13 1:50 PM | Zanotti Katherine S | Proposed Sale | 3,207 | $53.20 | $170.6K | — | View → |
| Oct 8, 2024 | Oct 8 5:27 PM | Baranick Brian | Proposed Sale | 929 | $70.00 | $65.0K | — | View → |
| Sep 18, 2024 | Sep 18 8:15 PM | Baranick Brian | Proposed Sale | 929 | $70.00 | $65.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Mar 23 1:21 PM | Brian BaranickEVP, GM, Precision Oncology | Disposition | 28,063 | — | 0(D) | View → |
| Mar 23, 2026 | Mar 23 1:20 PM | James HerriottSVP, General Counsel & Sec | Disposition | 23,975 | $98.18 | 0(D) | View → |
| Mar 23, 2026 | Mar 23 1:20 PM | Aaron BloomerEVP, Chief Financial Officer | Disposition | 32,458 | — | 0(D) | View → |
| Mar 23, 2026 | Mar 23 1:20 PM | Sarah CondellaEVP, Human Resources | Disposition | 71,243 | $98.18 | 0(D) | View → |
| Mar 23, 2026 | Mar 23 1:20 PM | Kevin T ConroyDirector, President and CEO | Disposition | 737,129 | $98.18 | 0(D) | View → |
| Mar 23, 2026 | Mar 23 1:19 PM | Jacob A OrvilleEVP, GM, Screening | Disposition | 45,288 | $98.18 | 0(D) | View → |
| Mar 23, 2026 | Mar 23 1:19 PM | Scott D CowardDirector | Disposition | 27,836 | $98.18 | 0(D) | View → |
| Mar 23, 2026 | Mar 23 1:18 PM | Michael J BarberDirector | Disposition | 7,422 | $0.00 | 0(D) | View → |
| Feb 27, 2026 | Mar 4 12:16 AM | Kevin T ConroyDirector, President and CEO | Option Exercise | 68,097 | — | 83,360(D) | View → |
| Feb 27, 2026 | Mar 4 12:16 AM | Sarah CondellaEVP, Human Resources | Option Exercise | 3,900 | $5.03 | 0(D) | View → |
| Feb 25, 2026 | Feb 27 9:30 PM | Sarah CondellaEVP, Human Resources | Grant/Award | 23,224 | — | 23,224(D) | View → |
| Feb 25, 2026 | Feb 27 9:30 PM | James HerriottSVP, General Counsel & Sec | Grant/Award | 20,321 | — | 20,321(D) | View → |
| Feb 25, 2026 | Feb 27 9:30 PM | Kevin T ConroyDirector, President and CEO | Grant/Award | 154,829 | — | 154,829(D) | View → |
| Feb 25, 2026 | Feb 27 9:30 PM | Brian BaranickEVP, GM, Precision Oncology | Grant/Award | 28,063 | — | 28,063(D) | View → |
| Feb 25, 2026 | Feb 27 9:30 PM | Jacob A OrvilleEVP, GM, Screening | Grant/Award | 38,707 | — | 38,707(D) | View → |
| Feb 25, 2026 | Feb 27 9:30 PM | Aaron BloomerEVP, Chief Financial Officer | Grant/Award | 28,063 | — | 28,063(D) | View → |